4 Recruiting Studies Using Azd9833
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Azd9833
🔵 Active, Not Recruiting Phase1 💊 Investigational Drug / Biologic
Study of AZD9833 Alone or in Combination in Women With Advanced Breast Cancer.
📍 Research Site — Aurora, Colorado
ER+ HER2- Advanced Breast Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase2 💊 Investigational Drug / Biologic
A Study to Investigate Efficacy and Safety With Oral AZD9833 Compared With Intramuscular Fulvestrant in Post-menopausal Women at Least 18 Years of Age With Advanced ER-positive HER2 Negative Breast Cancer
📍 Research Site — Birmingham, Alabama
Advanced ER-Positive HER2-Negative Breast Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
A Comparative Study of AZD9833 Plus Palbociclib Versus Anastrozole Plus Palbociclib in Patients With ER-Positive HER2 Negative Breast Cancer Who Have Not Received Any Systemic Treatment for Advanced Disease
📍 Research Site — Mobile, Alabama
ER-Positive HER2-Negative Breast Cancer
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Phase III Study to Assess AZD9833+ CDK4/6 Inhibitor in HR+/HER2-MBC With Detectable ESR1m Before Progression (SERENA-6)
📍 Research Site — Phoenix, Arizona
ER-Positive HER2-Negative Breast Cancer
View Study & Checklist ➔